At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Apr 1, 2026 at 08:15 ET
Profound Medical announced that its TULSA-PRO system and the MRI-guided TULSA Procedure will be featured in multiple presentations at the 2026 Society of Interventional Radiology (SIR) Annual Meeting, including data from the CAPTAIN trial and real-world clinical experience. While the event increases visibility for the technology, no new clinical results, regulatory decisions, or commercial updates were disclosed. This is a promotional awareness event, not a material clinical or regulatory milestone.
- TULSA-PRO and TULSA Procedure will be highlighted in multiple oral and featured presentations at SIR 2026 Annual Meeting in Toronto (April 11–15, 2026).
- Presentations include CAPTAIN trial data (Level 1 evidence), real-world experience, and a meta-analysis of oncologic and functional outcomes.
- No new clinical data, FDA decisions, or commercial updates were released.
- The event is a scientific conference presentation, not a regulatory or commercial catalyst.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access